Thumbnail Image
Item

Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection

Kaushik, Ajeet
; 
Yndart, Adriana
; 
Atluri, Venkata
; 
Tiwari, Sneham
; 
Tomitaka, Asahi
; 
Gupta, Purnima
; 
Jayant, Rahul Dev
; 
Alvarez-Carbonell, David
; ; 
Nair, Madhavan
Citations
Altmetric:
Genre
Journal article
Date
2019-03-08
Advisor
Committee member
Group
Department
Neuroscience
Subject
Biotechnology
 Health care
Permanent link to this record
http://hdl.handle.net/20.500.12613/8760
Collections
Faculty/Researcher Works
Show all metadata
Files
Thumbnail Image
Khalili-JournalArticle-2019.pdf
Adobe PDF, 3.92 MB
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1038/s41598-019-40222-4
Abstract
CRISPR-Cas9/gRNA exhibits therapeutic efficacy against latent human immunodeficiency virus (HIV) genome but the delivery of this therapeutic cargo to the brain remains as a challenge. In this research, for the first time, we demonstrated magnetically guided non-invasive delivery of a nano-formulation (NF), composed of Cas9/gRNA bound with magneto-electric nanoparticles (MENPs), across the blood-brain barrier (BBB) to inhibit latent HIV-1 infection in microglial (hμglia)/HIV (HC69) cells. An optimized ac-magnetic field of 60 Oe was applied on NF to release Cas9/gRNA from MENPs surface and to facilitate NF cell uptake resulting in intracellular release and inhibition of HIV. The outcomes suggested that developed NF reduced HIV-LTR expression significantly in comparison to unbound Cas9/gRNA in HIV latent hμglia/HIV (HC69) cells. These findings were also validated qualitatively using fluorescence microscopy to assess NF efficacy against latent HIV in the microglia cells. We believe that CNS delivery of NF (CRISPR/Cas9-gRNA-MENPs) across the BBB certainly will have clinical utility as future personalized nanomedicine to manage neuroHIV/AIDS.
Description
Citation
Kaushik, A., Yndart, A., Atluri, V. et al. Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection. Sci Rep 9, 3928 (2019). https://doi.org/10.1038/s41598-019-40222-4
Citation to related work
Nature Research
Has part
Scientific Reports, Vol. 9
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
Embedded videos